| Megan Margaret Mazzei, LPN | |
|
2434 Se Belmont St, Portland, OR 97214-2821 | |
| (573) 639-2364 | |
| Not Available |
| Full Name | Megan Margaret Mazzei |
|---|---|
| Gender | Female |
| Speciality | Licensed Vocational Nurse |
| Location | 2434 Se Belmont St, Portland, Oregon |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396220406 | NPI | - | NPPES |
| NA | Other | NA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164X00000X | Licensed Vocational Nurse | 201808389 (Oregon) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Megan Margaret Mazzei, LPN 2434 Se Belmont St, Portland, OR 97214-2821 Ph: (573) 639-2364 | Megan Margaret Mazzei, LPN 2434 Se Belmont St, Portland, OR 97214-2821 Ph: (573) 639-2364 |
News Archive
Amgen today announced that detailed results from two pivotal Phase 3 studies evaluating Vectibix® (panitumumab) in combination with chemotherapy for the first and second-line treatment of metastatic colorectal cancer (mCRC) (the PRIME '203' and '181' trials, respectively) will be presented at the 2010 American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium in Orlando, Florida from Jan. 22-24, 2010.
Discoveries by IU School of Medicine scientists have opened a promising door to new drugs for toxoplasmosis and other parasites that now can evade treatments by turning dormant in the body.
Pharmaceutical Institute, a leading provider of specialized training solutions for the pharmaceutical and biotech industry, today announced the launch of a new e-course titled, Hospital Marketplace. The new Hospital Marketplace e-course is the newest addition to the company's Managed Markets Excellence(TM) series, a comprehensive series of e-courses designed to fill the critical need for basic and advanced managed markets knowledge for commercial professionals.
When it comes to cell signaling and bioregulation, it's tough to find a more important molecule than nitric oxide (NO). Dysfunction of NO-mediated signaling is thought to be a culprit in lethal cardiovascular conditions such as angina, and septic, cardiogenic and hemorrhagic shock; it may play a role in many other illnesses as well.
› Verified 3 days ago
Barbara Rebecca Albert, Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 420 Ne Mason St, Portland, OR 97211 Phone: 503-546-9565 | |
Donna Cole, Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 3710 Sw Us Veterans Hospital Rd, Portland, OR 97239 Phone: 503-220-8262 Fax: 503-273-5210 | |
Aisha Stancil, LPN Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 420 Ne Mason St, Portland, OR 97211 Phone: 506-546-9551 Fax: 503-546-3465 | |
Sulay Ordovas, RN Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 1132 Sw 13th Ave, Portland, OR 97205 Phone: 503-535-3860 Fax: 415-553-3119 | |
Kayleen Adams, Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 3710 Sw Us Veterans Hospital Rd, Portland, OR 97239 Phone: 360-759-1901 | |
Christopher John Theonnes, Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 3710 Sw Us Veterans Hospital Rd # V5move, Portland, OR 97239 Phone: 503-220-8262 |